Merck
MRK
#62
Rank
HK$1.938 T
Marketcap
HK$776.26
Share price
-1.16%
Change (1 day)
-1.07%
Change (1 year)

EPS for Merck (MRK)

EPS in 2025 (TTM): HK$59.18

According to Merck's latest financial reports the company's current EPS (TTM) is HK$59.11. In 2024 the company made an earnings per share (EPS) of HK$52.62 an increase over its 2023 EPS that were of HK$1.19.

EPS history for Merck from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)HK$59.1812.48%
2024HK$52.624308.46%
2023HK$1.19-97.32%
2022HK$44.6010.92%
2021HK$40.2184.68%
2020HK$21.78-27.2%
2019HK$29.9163.44%
2018HK$18.30151.11%
2017HK$7.29-54.58%
2016HK$16.0430.21%
2015HK$12.32-61.99%
2014HK$32.41180.51%
2013HK$11.55-31.82%
2012HK$16.956.62%
2011HK$15.89

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
HK$13.39-77.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$81.26 37.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$159.72 170.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$23.12-60.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$28.85-51.20%๐Ÿ‡ซ๐Ÿ‡ท France
GlaxoSmithKline
GSK
HK$27.99-52.65%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
HK$4.90-91.70%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
HK$57.29-3.08%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Abbott Laboratories
ABT
HK$62.72 6.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$101.43 71.59%๐Ÿ‡บ๐Ÿ‡ธ USA